Sign up to save your podcasts
Or
Share Sjögren’s Disease is When the Immune System Chases Its Own Tail
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Sjögren’s Disease is When the Immune System Chases Its Own Tail
In this week's episode, we talk about Sjögren's disease, a relatively common autoimmune disease. We explore the risks of contracting the disease, who gets it, symptoms, and complications. We also explore how the disease works on a mechanical level inside the body by hijacking the immune system, and finish by looking at what treatment looks like today and what's coming down the clinical trial pipeline tomorrow.
References:
- Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clinical epidemiology. 2014 Jul 30:247-55. https://doi.org/10.2147/clep.s47399
- Mariette X, Criswell LA. Primary Sjögren’s syndrome. New England Journal of Medicine. 2018 Mar 8;378(10):931-9. https://doi.org/10.1056/NEJMcp1702514
- Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren’s syndrome. Deutsches Ärzteblatt International. 2017 May 26;114(20):354.https://doi.org/10.3238/arztebl.2017.0354
- Baldini C, Fulvio G, La Rocca G, Ferro F. Update on the pathophysiology and treatment of primary Sjögren syndrome. Nature Reviews Rheumatology. 2024 Aug;20(8):473-91. https://doi.org/10.1038/s41584-024-01135-3
- Yang Y, Shen Z, Shi F, Wang F, Wen N. Efgartigimod as a novel FcRn inhibitor for autoimmune disease. Neurological Sciences. 2024 Sep;45(9):4229-41. https://link.springer.com/article/10.1007/s10072-024-07460-5
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
View all episodes
By MedEvidence ArticlesIn this week's episode, we talk about Sjögren's disease, a relatively common autoimmune disease. We explore the risks of contracting the disease, who gets it, symptoms, and complications. We also explore how the disease works on a mechanical level inside the body by hijacking the immune system, and finish by looking at what treatment looks like today and what's coming down the clinical trial pipeline tomorrow.
References:
- Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clinical epidemiology. 2014 Jul 30:247-55. https://doi.org/10.2147/clep.s47399
- Mariette X, Criswell LA. Primary Sjögren’s syndrome. New England Journal of Medicine. 2018 Mar 8;378(10):931-9. https://doi.org/10.1056/NEJMcp1702514
- Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren’s syndrome. Deutsches Ärzteblatt International. 2017 May 26;114(20):354.https://doi.org/10.3238/arztebl.2017.0354
- Baldini C, Fulvio G, La Rocca G, Ferro F. Update on the pathophysiology and treatment of primary Sjögren syndrome. Nature Reviews Rheumatology. 2024 Aug;20(8):473-91. https://doi.org/10.1038/s41584-024-01135-3
- Yang Y, Shen Z, Shi F, Wang F, Wen N. Efgartigimod as a novel FcRn inhibitor for autoimmune disease. Neurological Sciences. 2024 Sep;45(9):4229-41. https://link.springer.com/article/10.1007/s10072-024-07460-5
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!